Dna-pk inhibitors

ME03250BActive Publication Date: 2019-07-20VERTEX PHARMACEUTICALS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ME2018308
Authority / Receiving Office: ME · ME
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2013-04-23
Filing Date: 2013-04-23
Publication Date: 2019-07-20
Estimated Expiration: 2033-04-23

Application Information

Patent Timeline

23 Apr 2013

Priority

23 Apr 2013

Application

ME2018308

20 Jul 2019

Publication

ME03250B

IPC: C07D239/42; C07D401/04; C07D401/14; C07D403/04; C07D403/10; C07D405/14; C07D409/04; C07D409/14; C07D413/04; C07D413/10; C07D413/14; C07D417/04; C07D417/14; C07D471/04; C07D491/048

CPC: A61K41/0038; C07D239/42; C07D401/04; C07D401/14; C07D403/04; C07D403/10; C07D405/14; C07D409/04

Inventors: MORRIS Mark A.; PIERCE Albert Charles

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.